Archives

by in
Entry Author Date Location
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
$5M Debt Deal for Dicerna Pharma 06/30/10 Boston
Zipcar Files for $75M IPO, Tetraphase Gets $45M, Covidien Acquires ev3 for $2.6B, & More Boston-Area Deals News 06/02/10 Boston
TetraPhase Pharmaceuticals Receives $45,000,000 Series C Financing 06/01/10 Boston
Halozyme Announces Recall, Pathway Genomics Halts Genetic Test Kit Rollout, Vertex Gets Ready for Hepatitis C Results, & More San Diego Life Sciences News 05/20/10 San Diego
Celula Receives $15,000,000 Series B Round 05/19/10 San Diego
San Diego’s Celula Gets $15M for Molecular Diagnostics 05/18/10 San Diego
Tolerx, After a Decade and $150M, Eagerly Awaits Data from Big Diabetes Trial 03/04/10 Boston
Dicerna Snags Deal With Japan’s Kyowa Hakko Kirin to Develop RNAi Cancer Treatments 01/04/10 Boston
Calibra Medical Secures $1,400,000 New Funding 11/24/09 San Francisco
Washington Companies Raised $84.9M in September—But Mostly in One Deal 10/08/09 Seattle
Satiety Receives $25,300,000 New Financing 09/30/09 San Francisco
Free & Clear Acquired for $100M-Plus, Calypso Gets $50M, Ensequence Ensnares $20M, & More Seattle-Area Deals News 09/22/09 Seattle
How Did Calypso Raise $50M? The Story Behind Seattle’s Biggest VC Deal of 2009 09/18/09 Seattle
Calypso Medical Raises $50M to Strengthen Pinpointed Radiation Therapy for Cancer 09/17/09 Seattle
Calypso Medical Technologies Secures $50,000,000 New Financing 09/17/09 Seattle
San Diego Biotech Startups Raise New Cash to Treat Anemia, Heart Disease and More 08/19/09 San Diego
Novasys Medical Garners $18,950,000 Series D Funding Round 07/21/09 San Francisco
Proteon Adds $12M To B Round 05/28/09 Boston
U.S. Venture Funding Plummets (Yada Yada), But New England Less So—Region’s Top 10 Deals of Q1 04/20/09 Boston
InteKrin Therapeutics Lands $927,000 New Funding 03/31/09 San Francisco
Vertex Puts up $375M for ViroChem, Nuance Finally Nabs Zi, Proteon Procures $38M, & More Boston-Area Deals News 03/06/09 Boston
Proteon Therapeutics Inc. Secures $38,000,000 Series B Financing 03/05/09 Boston
Dicerna Aims to Gain Foothold in RNAi World With More Potent, Longer-Lasting Gene Silencers 01/30/09 Boston
DiscoveRx Corporation Ltd. Lands $4,000,000 New Funding 12/31/08 San Francisco
Biogen Idec Makes Controversial Tysabri Decision, Boston Scientific Explains Stock Sales, Charles River Heads to China, & More Boston-Area Life Sciences News 10/16/08 Boston
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV 10/14/08 Boston
Concert Pharmaceuticals Enters Clinical Trials with Drug for Hot Flashes 09/25/08 Boston
Follica’s Fortunes Growing, Icahn’s Biogen Holdings Mounting, Genzyme’s Mipomersen Work Progressing, & More Life Sciences News 08/13/08 Boston
A123 Files For “Lucky” IPO, BP Shells out $90M for Verenium’s Biofuel Tech, Alnylam Ventures into New RNA Realm, & More Deals News 08/11/08 Boston
Page 2 of 3 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.